Risk assessment of arrhythmias related to three antiseizure medications: a systematic review and single-arm meta-analysis

Risk assessment of arrhythmias related to three antiseizure medications: a systematic review and single-arm meta-analysis

ObjectiveAntiseizure medications (ASMs) are first line therapy for seizure disorders. Their effects on arrhythmias, especially the risk of arrhythmias associated with lacosamide (LCM), levetiracetam (LEV), and perampanel (PER), have been intensely investigated.MethodsWe searched four databases (PubM...

Full description

Bibliographic Details
Main Authors:	Yulong Li, Shen Su, Mengwen Zhang, Limin Yu, Xinyuan Miao, Hongjun Li, Yanping Sun
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-02-01
Series:	Frontiers in Neurology
Subjects:	antiseizure medications epilepsy arrhythmias levetiracetam lacosamide perampanel
Online Access:	https://www.frontiersin.org/articles/10.3389/fneur.2024.1295368/full

Similar Items

Serum perampanel levels in patients with seizures are not affected by hemodialysis
by: Yusuke Nakazawa, et al.
Published: (2024-08-01)

Comparative safety analysis of lacosamide and perampanel in epilepsy management: insights from FAERS database
by: Chang Ge, et al.
Published: (2024-09-01)

Perampanel’s forgiveness factor in a variable medication adherence paradigm in a rat model of chronic epilepsy
by: Michelle Guignet, et al.
Published: (2023-09-01)

Neuropharmacology of Antiseizure Drugs
by: Tahir Hakami
Published: (2021-09-01)

Loss of normal Alzheimer's disease-associated Presenilin 2 function alters antiseizure medicine potency and tolerability in the 6-Hz focal seizure model
by: Leanne M. Lehmann, et al.
Published: (2023-08-01)

A novel action of lacosamide on GABAA currents sets the ground for a synergic interaction with levetiracetam in treatment of epilepsy
by: Gabriele Ruffolo, et al.
Published: (2018-07-01)

A 5-Year Study of Antiseizure Medications (ASMs) Monitoring in Patients with Neuropsychiatric Disorders in an Italian Clinical Center
by: Letizia Biso, et al.
Published: (2023-06-01)

Effects of Levetiracetam and Lacosamide on survival and seizure control in IDH-wild type glioblastoma during temozolomide plus radiation adjuvant therapy
by: Andrea Bianconi, et al.
Published: (2024-01-01)

Modern management of seizures and epilepsy
by: Markus Gschwind, et al.
Published: (2016-06-01)

Efficacy and safety of levetiracetam as adjunctive therapy for refractory focal epilepsy
by: Maria Luiza Giraldes de MANREZA, et al.
Published: (2021-06-01)

The 4-Aminopyridine Model of Acute Seizures in vitro Elucidates Efficacy of New Antiepileptic Drugs
by: Hanno Heuzeroth, et al.
Published: (2019-06-01)

A meta-analytic evaluation of the efficacy and safety of levetiracetam for treating myoclonic seizures
by: Sara Najafi, et al.
Published: (2025-02-01)

Multicentric study of adherence to antiseizure medications among adults with epilepsy attended in neurology departments in Burkina Faso
by: Alfred Anselme Dabilgou, et al.
Published: (2025-02-01)

Cardiac Dysfunction Associated with Lacosamide in a Premature Infant with Hypoxic Ischemic Encephalopathy: A Case Report
by: Trassanee Chatmethakul, et al.
Published: (2024-07-01)

Development and Validation of a Simple HPLC-UV Assay Method for Determination of Levetiracetam Concentrations in Human Plasma
by: Maged Kharouba, et al.
Published: (2023-01-01)

Lacosamide-associated second-degree atrioventricular block in a healthy, young athlete
by: Brian Stamm, et al.
Published: (2020-01-01)

Case report of antiseizure medicine-induced long QT syndrome and a literature review
by: Xiongying Yu, et al.
Published: (2022-11-01)

Clinical outcomes and treatments effectiveness in status epilepticus resolved by antiepileptic drugs: A five‐year observational study
by: Niccolò Orlandi, et al.
Published: (2020-06-01)

Antiseizure medication withdrawal risk estimation and recommendations: A survey of American Academy of Neurology and EpiCARE members
by: Samuel W. Terman, et al.
Published: (2023-06-01)

Therapeutic Potential of Mesenchymal Stem Cells in the Treatment of Epilepsy and Their Interaction with Antiseizure Medications
by: Maryam Rahimi Tesiye, et al.
Published: (2022-12-01)

Availability, price, and affordability of antiseizure medicines in Addis Ababa, Ethiopia
by: Fikreselam Habte Hailemariam, et al.
Published: (2023-09-01)

The impact of epilepsy and antiseizure medications on pregnancy and neonatal outcomes: A nationwide cohort study
by: Cheng‐Yen Kuo, et al.
Published: (2023-12-01)

A retrospective review of changes and challenges in the use of antiseizure medicines in Dravet syndrome in Norway
by: Katrine Heger, et al.
Published: (2020-09-01)

Trends in use of antiseizure medication and treatment pattern during the first trimester in the German Embryotox cohort
by: Maria Hoeltzenbein, et al.
Published: (2024-12-01)

Incidence of and predictors for antiseizure medication gaps in Medicare beneficiaries with epilepsy: a retrospective cohort study
by: Samuel W. Terman, et al.
Published: (2022-09-01)

Perampanel as first add-on antiseizure medication: Italian consensus clinical practice statements
by: Paolo Bonanni, et al.
Published: (2021-10-01)

Seizure control by adding on other anti-seizure medication on seizure during levetiracetam administration in patients with glioma-related epilepsy
by: Etsuko Yamamoto Hattori, et al.
Published: (2023-09-01)

BDNF/Cyclin D1 Signaling System and Cognitive Performance After Perampanel and Lacosamide Treatment Singly or in Combination in an Experimental Model of Temporal Lobe Epilepsy
by: Michaela Shishmanova-Doseva, et al.
Published: (2024-12-01)

The efficacy and safety of novel antiepileptic drugs in treatment of epilepsy of patients with brain tumors
by: Weiwei Zhai, et al.
Published: (2024-03-01)

Impact of depressive symptoms on adverse effects in people with epilepsy on antiseizure medication therapy
by: Jürgen Panholzer, et al.
Published: (2024-06-01)

Efficacy and safety of add‐on antiseizure medications for focal epilepsy: A network meta‐analysis
by: Hesheng Zhang, et al.
Published: (2024-08-01)

Retention rates of antiepileptic drugs in glioma patients: the most appropriate outcome
by: Pim B van der Meer, et al.
Published: (2020-06-01)

Evaluation of antiseizure drug efficacy and tolerability in the rat lamotrigine‐resistant amygdala kindling model
by: Cameron S. Metcalf, et al.
Published: (2019-09-01)

Levetiracetam may be an unsuitable choice for patients with PRRT2-associated self-limited infantile epilepsy
by: Yang Tian, et al.
Published: (2023-10-01)

Variation in seizure risk increases from antiseizure medication withdrawal among patients with well‐controlled epilepsy: A pooled analysis
by: Samuel W. Terman, et al.
Published: (2024-02-01)

Third generation antiepileptic drugs: mechanism of action, pharmacokinetics, interaction and use in childhood
by: Z. G. Tadtaeva, et al.
Published: (2023-07-01)

Evaluation of antiseizure medications including zonisamide in feline idiopathic epilepsy at a referral hospital in Japan
by: Shino Yoshida, et al.
Published: (2023-07-01)

Case Report: Lacosamide unmasking SCN5A-associated Brugada syndrome in a young female with epilepsy
by: Ying-Chi Shen, et al.
Published: (2024-05-01)

Clinical Experience with Adjunctive Lacosamide in Adult Patients with Focal Seizures
by: Demet İLHAN ALGIN, et al.
Published: (2017-08-01)

Unraveling the neuroprotective effect of perampanel and lacosamide combination in the corneal kindling model for epilepsy in mice
by: Saba Tehreem, et al.
Published: (2025-02-01)